169 related articles for article (PubMed ID: 38785978)
1. Hypermethylation of the Gene Body in
Shen HT; Hung CS; Davis C; Su CM; Liao LM; Shih HM; Lee KD; Ansar M; Lin RK
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785978
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer.
Lin RK; Su CM; Lin SY; Thi Anh Thu L; Liew PL; Chen JY; Tzeng HE; Liu YR; Chang TH; Lee CY; Hung CS
Mol Med; 2022 Jun; 28(1):67. PubMed ID: 35715741
[TBL] [Abstract][Full Text] [Related]
3. MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.
Yang F; Luo LJ; Zhang L; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
Gene; 2017 Feb; 600():21-28. PubMed ID: 27913185
[TBL] [Abstract][Full Text] [Related]
4. SRCIN1 Regulated by circCCDC66/miR-211 Is Upregulated and Promotes Cell Proliferation in Non-Small-Cell Lung Cancer.
Hong W; Yu S; Zhuang Y; Zhang Q; Wang J; Gao X
Biomed Res Int; 2020; 2020():5307641. PubMed ID: 32964035
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1.
Guo L; Zhu Y; Li L; Zhou S; Yin G; Yu G; Cui H
Cancer Med; 2019 Sep; 8(12):5687-5701. PubMed ID: 31385464
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Hung CS; Wang SC; Yen YT; Lee TH; Wen WC; Lin RK
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30308939
[TBL] [Abstract][Full Text] [Related]
8. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Srcin1 contributes to the growth and metastasis of colorectal cancer.
Zhang M; Ma F; Xie R; Wu Y; Wu M; Zhang P; Peng Y; Zhao J; Xiong J; Li A; Kequan C; Zhang Y; Liu S; Wang J; Chen X
Int J Oncol; 2017 May; 50(5):1555-1566. PubMed ID: 28393242
[TBL] [Abstract][Full Text] [Related]
10. Large-scale analysis of
Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
[TBL] [Abstract][Full Text] [Related]
11. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
12. SRCIN1 Suppressed Osteosarcoma Cell Proliferation and Invasion.
Wang P; Wang H; Li X; Liu Y; Zhao C; Zhu D
PLoS One; 2016; 11(8):e0155518. PubMed ID: 27513473
[TBL] [Abstract][Full Text] [Related]
13. CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Martín-Sánchez E; Mendaza S; Ulazia-Garmendia A; Monreal-Santesteban I; Blanco-Luquin I; Córdoba A; Vicente-García F; Pérez-Janices N; Escors D; Megías D; López-Serra P; Esteller M; Illarramendi JJ; Guerrero-Setas D
Oncotarget; 2017 Feb; 8(9):15789-15801. PubMed ID: 28178655
[TBL] [Abstract][Full Text] [Related]
14. miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.
Cao M; Hou D; Liang H; Gong F; Wang Y; Yan X; Jiang X; Wang C; Zhang J; Zen K; Zhang CY; Chen X
Eur J Cancer; 2014 Mar; 50(5):1013-24. PubMed ID: 24456795
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis.
Zhang W; Wang H; Qi Y; Li S; Geng C
Sci Rep; 2022 Feb; 12(1):1989. PubMed ID: 35132081
[TBL] [Abstract][Full Text] [Related]
16. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
17. Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients.
Li SY; Li R; Chen YL; Xiong LK; Wang HL; Rong L; Luo RC
BMC Genet; 2014 Jun; 15():67. PubMed ID: 24919593
[TBL] [Abstract][Full Text] [Related]
18. miR-150-5p promotes the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via targeting SRCIN1.
Zhu J; Han S
Pathol Res Pract; 2019 Apr; 215(4):738-747. PubMed ID: 30679084
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation and breast cancer: A way forward (Review).
Vietri MT; D'Elia G; Benincasa G; Ferraro G; Caliendo G; Nicoletti GF; Napoli C
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34726251
[TBL] [Abstract][Full Text] [Related]
20. miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction.
Zhang Y; Yuan J; Guo M; Xiang R; Wang X; Xie T; Zhuang X; Li Q; Lai Q
Dis Markers; 2022; 2022():4842454. PubMed ID: 36033827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
